SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Mankind Pharma Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
543904 INE634S01028 240.2139154 MANKIND 0 83,816.88 45.97 45.51 1
Quarters :
ParticularsMar 2024(Rs.Cr)Dec 2023(Rs.Cr)Sep 2023(Rs.Cr)
Gross Sales2152.692358.572453.35
Other Operating Income0.000.000.00
Other Income 83.8567.2358.12
Total Income2236.542425.802511.46
Total Expenditure 1605.351755.461818.15
PBIDT631.19670.34693.31
Interest 4.034.264.31
PBDT627.15666.08689.00
Depreciation82.2989.7377.04
Tax110.6574.41122.25
Fringe Benefit Tax0.000.000.00
Deferred Tax-19.9614.8716.82
Reported Profit After Tax454.17487.07472.88
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item454.17487.07472.88
    
EPS (Unit Curr.)11.3412.1611.80
EPS (Adj) (Unit Curr.)11.3412.1611.80
Calculated EPS (Unit Curr.)11.3412.1611.80
Calculated EPS (Adj) (Unit Curr.)11.3412.1611.80
Calculated EPS (Ann.) (Unit Curr.)45.3548.6447.22
Calculated EPS (Adj) (Ann.) (Unit Curr.)45.3548.6447.22
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity40.0640.0640.06
Reserve & Surplus0.000.000.00
Face Value1.001.001.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)29.3228.4228.26
PBDTM(%)29.1328.2428.08
PATM(%)21.1020.6519.27